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Case Report
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Description

Gender dysphoria occurs when a discrepancy between one’s sex assigned at birth and one’s
gender identity causes distress or impairment in function, which can lead ultimately to seeking treatment in the forms of psychotherapy, hormonal therapy, and/or gender-affirming
surgery. Clinical care guidelines also recommend pharmacological treatment of psychiatric
comorbidities if indicated. A review of the current literature demonstrates comorbidity between gender dysphoria and psychosis, including cases of gender dysphoria with schizophrenia and the occurrence of gender dysphoria symptoms during manic or psychotic episodes.
The existing literature has yet to specifically examine gender dysphoria amongst individuals
with schizoaffective disorder. The authors present the first documented case of a clear
pattern of gender identity variations coinciding solely with psychotic episodes during schizoaffective disorder, bipolar type. The authors postulate that gender dysphoria can co-occur
with other psychiatric disorders or may correspond only during acute psychosis. The distinction is critical to make to ensure accurate diagnoses regarding whether gender dysphoria is
a symptom only during an acute psychotic illness, or if there is a longer-standing concern as
to the patient’s gender identity and assignment. This distinction then also informs how to
make the most appropriate treatment recommendations. The authors address the significance of understanding each patient's individual circumstances and deem this paramount to
advancing transgender and gender non-binary health equity at every level of medical attention, focusing specifically on proper physician training and direct patient care.
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Introduction

Gender dysphoria is the distress or discomfort that occurs when there is a discrepancy
between one’s sex assigned at birth and one’s
gender identity. This discomfort can ultimately lead to seeking treatment in the forms of
psychotherapy, hormonal therapy, and/or gender-affirming surgery, as well as pharmacological management of psychiatric comorbidities
as appropriate.1,2 A review of the current literature reports patient cases of gender dysphoria
comorbid with schizophrenia, as well as gender
dysphoric presentation during manic or psy-

chotic episodes.3.4 Studies demonstrate up to
25% of patients with schizophrenia experience
signs of gender dysphoria throughout their
lives, including beliefs regarding belonging to
another gender.2 Gender dysphoria occurring
solely during psychotic breaks exclusively with
schizoaffective disorder, and a progressively intensifying identification with a different
gender associated with acute schizoaffective
illness has not been documented in the literature. However, overlapping polygenetic and
environmental contributions to schizophrenia
and bipolar disorders is possible.
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Most presentations of gender dysphoria are
not difficult to diagnose.5 However, for unique
presentations of gender dysphoria—particularly
those with co-existent psychiatric conditions—
challenges in diagnosis can occur. Per the
World Professional Association for Transgender
Health (WPATH) Guidelines for treatment, to
obtain hormone replacement therapy (HRT),
patients must demonstrate a capacity to make
well-informed decisions, exemplify persistent
and well-documented gender dysphoria, and
all additional medical, physical, and mental
health concerns should be considered medically
stable.6,7 Additionally, if a patient seeks surgical
treatment in the form of chest reconstruction
or other non-genital procedures, the patient
additionally requires 1 letter from a mental
healthcare provider. If the patient desires genital reconstructive surgery, 1 full year of continuous hormone therapy, along with 2 letters
from two separate healthcare providers, is
required.6-8
There is a paramount need for expansion of
awareness, knowledge, and experience with
gender dysphoria, for both general practitioners and general psychiatrists, to ensure a
proper diagnosis and equitable and appropriate treatment. Health equity is the principle
underlying a commitment to minimize, and
ultimately eliminate, disparities in health and
its social determinants.8 Striving for health
equity requires striving for the highest possible standard of health for all and providing
special consciousness to the needs of those
at the greatest risk of poor health as a result
of social, economic, and environmental conditions. In making health equity a shared vision
and value, it is possible to foster equal opportunity for health, the foundation for a vigorous
and healthy community.9 Understanding each
patient's individual circumstances is crucial to
advancing health equity at every level of medicine. Given the growing body of evidence of
extreme health inequity among patients who
are gender diverse, it is essential to explore
case presentations of those who present with
both typical and unique presentations of gender dysphoria.4,10

Case Description

In this case report, the patient will be referred
to without using pronouns given fluctuations
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in pronouns over time. A 35-year-old Hispanic
person, assigned male at birth (AMAB), identified as female upon admission. The patient
denied any significant or contributing past
medical history. The patient had a past psychiatric history of schizoaffective disorder,
bipolar type, and presented involuntarily to the
psychiatric inpatient unit for bizarre behavior
and auditory hallucinations for the past three
months. Per the patient’s mother’s report, the
patient had been refusing to eat, was easily
agitated, and was exhibiting signs of mania,
including decreased sleep, and increased sexual
behavior. The patient reported medication
nonadherence for an unknown amount of time.
The patient denied the previous existence of a
female identity. Upon admission, the patient
presented in masculine clothing and identified
as a female, requesting that staff use she/her/
hers pronouns.
Social Context: The patient was an only child
and lived with the patient’s mother in a single-family home. The patient was unemployed
at the time of admission. The patient’s highest
level of education was a high school diploma.
The patient refused to discuss sexual orientation but did disclose having sexual relations
with men and women. The patient denied a
history of trauma or experiences of discrimination. The patient also denied a family history of
psychiatric illness or gender dysphoria.
Collateral (reported by patient’s mother):
The treating physician perceived the patient’s
mother’s perspective of fluctuations in gender
identity to be neutral. In other words, the patient’s mother did not express any explicitly anti-transgender attitudes. The patient’s mother
reported that with all psychotic breaks since
the age of 21 (age of first psychotic break), the
patient identified as a female, with an immediate reversal to male identification upon stabilization of the acute psychosis. Prior to this
age, no gender nonconformity was revealed to
the mother by the patient nor did the patient’s mother ever discuss or address gender
nonconformity with the patient. The patient’s
mother reported that during a previous psychotic break, the patient identified as female.
The patient survived a serious opioid overdose
that had resulted in a coma of 13-days duration.
Upon awakening and with medical stabilization,
the patient immediately transitioned to a male
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Table 1. DSM-5 Diagnostic Criteria for Gender Dysphoria in Children and Adults11

Gender Dysphoria DSM V Diagnostic Criteria
Children (6/8 required for at least 6 months)

Adults (2/6 required for at least 6 months)

•

•

•
•
•
•
•
•
•

Desire to be or insistance that one is another gender (required for diagnosis)
Wearing opposite gender clothes
Preferring opposite gender roles at playtime
Preferring toys/games/activities of opposite gender
Preferring playmates of opposite gender
Rejection of toys/games/activities typical
of native gender
Strong dislike of sexual anatomy
Desire for primary and/or secondary sexual
characteristics of experienced gender

identity. Upon returning home from the hospital, the patient got a crew cut and threw out
all feminine products and décor. The patient's
mother expressed that the patient was very
troubled by the changes throughout each psychotic break. Upon recognizing a clear pattern,
the patient’s mother began saving and storing
all female clothing, accessories, and décor in
the attic for future use. With each successive
break, the patient’s presentation exhibited a
progressive nature, commencing with laser
body hair removal, then feminizing hormone
therapy, then obtaining one of two required
letters for gender-affirming genital surgery.
Each successive break did show a lengthening
in time and an increase in severity. There were a
total of 5 psychotic breaks.

Physical Examination

General Assessment: Upon initial assessment,
the patient appeared thin and frail, and exhibited extreme emotional lability.
Vital Signs: Heart Rate: 97 beats per minute,
Respiratory Rate: 18 breaths per minute, Blood
Pressure: 110/71mmHg, 02 Saturation: 98%
BMI: 20
Examination: Unremarkable
Labs: WNL
Urine Drug Screen: Negative
Blood Alcohol Level: WNL
Std Panel: Negative
HIV: Negative

Treatment

Risperidone 0.5 mg twice daily and valproic
acid 500 mg twice daily were initiated. Risperdal was titrated up to 1.0 mg twice daily over

•
•
•
•

Incongruence between primary/secondary
sexual characteristics of one's natal gender
and that of experienced gender
Desire to avoid or be free of the sexual
characteristics of natal gender
Longing for sexual characteristics of another gender
Longing to be treated as another gender
Believing that their feelings and/or reactions are of another gender

the course of the hospitalization. Group and
individual therapy were provided, and a family
session was held to ensure a safe discharge
home. The patient’s condition stabilized over
the course of the hospitalization, the patient
no longer identified as a female and requested
that the mother bring male clothing. All psychotic symptoms including hallucinations resolved completely. The patient was discharged
after 8 days of hospitalization, with follow-up
recommended. To this date, the patient has not
presented back to this hospital.

Discussion

This case presentation extends a sparse literature concerning progressive episodes of gender dysphoria coinciding solely with psychotic
breaks of schizoaffective disorder, bipolar
type. No studies have yet examined gender
dysphoria symptoms occurring in the context
of psychosis among individuals with schizoaffective disorder, as it tends to not be seen or
correctly identified routinely in clincal practice.
This case presentation suggests that gender
dysphoria can have a complex interrelationship
with comorbid disorders, such as schizoaffective disorder. Additionally, this report demonstrates the patient’s continuity of transgender
identity across psychotic episodes. The authors
review neurobiological research as well as identify challenges in diagnosing gender dysphoria
(Table 1) and ensuring appropriate treatment
(Table 2), provide suggestions on addressing
these challenges, and discuss the significance
of a thorough history evaluation and collection
of collateral information.
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Table 2. Criteria for Initiation of Hormonal and Surgical Treatment with Gender Dysphoria12
Treatment

Criteria for initiation

Hormonal therapy

•
•
•

Persistent and well-documented gender dysphoria
Capacity to make well-informed decisions
Other medical and mental health issues are well controlled

Surgical treatment

•
•

Same as above, plus:
1 year of continuous hormone therapy and 1 year living as desired
gender (unless not medically indicated)
Not required for chest reconstruction or non-genital surgeries
Chest Surgery: 1 letter from mental healthcare provider
Genital Surgery: 2 letters from separate mental healthcare providers

•

The literature indicates a significant comorbidity between schizophrenia and gender dysphoria. Much of the literature suggests that a
diathesis-stress model accounting for minority
stress experienced by gender minorities may
explain this comorbidity.4,13 Some neurobiological research also suggests neurobiological
underpinnings for both mental health concerns.
Altered cerebral sexual dimorphism, or gender-atypical brain development (differing from
normal gender-specific brain development)
may be caused by differences in prenatal hormones and changes in cerebral lateralization.14,15
In individuals with gender dysphoria, brain
imaging studies demonstrate dimorphic brain
regions that reflect gender identity, rather than
anatomical sex (conventionally, larger volumes
of gray matter are seen within the left hemisphere in a male brain, while larger volumes of
gray matter are seen in the right hemisphere
of a female brain).14,16 Some brain structures
of individuals with schizophrenia demonstrate
a similar variation, where brains of cisgender
women with schizophrenia follow patterns
that are typical for cisgender men and brains
of cisgender men with schizophrenia follow
patterns that are typical for cisgender women.14-16 Thus, it is possible that fetal processes of
neurodiverse brain development—influenced by
prenatal hormones—affect the later expression
of schizophrenia and gender dysphoria (as well
as a host of other developmental and mental health concerns, such as autism spectrum
disorder).2
Additionally, several findings suggest a
non-normative pattern of cerebral lateralization and handedness in individuals with
schizophrenia as well as those with gender
dysphoria.17 A recent meta-analysis found that
individuals with schizophrenia had a higher
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incidence of left-handedness.17 Correspondingly, a recent study found that AMAB (assigned
male at birth) individuals with gender dysphoria demonstrated a significantly higher rate of
left-handedness.18 This common finding could
suggest a similar non-normative pattern of
lateralization in both schizophrenia and gender
dysphoria.
Neurobiological research also indicates common comorbid diagnoses between both schizophrenia and gender dysphoria, including Toxoplasma gondii infection/inflammation, autism
spectrum disorders (ASD), and reduced serum
brain-derived neurotrophic factor (BDNF).15,19
Although they are distinct mental health
concerns, ASD and schizophrenia substantially overlap on anatomical and neurocognitive
aspects of the brain.15 Similar to schizophrenia,
ASD is linked to differences in prenatal testosterone exposure, which is relevant to the
nature of gender dysphoria.15 Additionally, a
family history of schizophrenia is a known predisposing factor for ASD, implicating a genetic
link between the two.19,20 Decreased levels of
BDNF were found in a recent controlled study
of 45 male-to-female patients above the age
of 18 with gender dysphoria compared with 66
healthy male controls,21 hypothesized as consistent with psychological abuse, as exclusion
criteria included the presence of a comorbid
psychiatric disorder.21 Such findings suggest an
overlap in common biochemical pathways of
neuroplasticity, as well as both inherited and
acquired differences in brain development.
Unfortunately, it holds true that individuals
who fall outside of conceptions of “normality”
are deemed internally pathological, leading to
stigmatization, with resultant tribulation.22
To best support affected individuals, a more
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thoughtful approach would be to replace the
“disability” or “illness” paradigm with a “diversity” perspective, which in turn would consider
strengths, weaknesses, and the idea that variation can be positive in and of itself.22 Additionally, the language used to discuss this neurodiversity must be supportive of those living
with schizophrenia, schizoaffective disorder,
and gender dysphoria, rather than stigmatizing
language. Lastly, it is crucial to stray away from
the usage of the term “normal” when referring
to the brain and mind.23

to hormonal replacement therapy with later
episodes, and finally to obtaining 1 of 2 required
letters for sexual reassignment surgery. To
the authors’ knowledge, this case depicts the
first documentation of such a presentation.
The authors postulate long-term antipsychotic
use as a major contributing factor, due to the
up-regulation of D2 receptors and subsequent
dopamine receptor supersensitivity, leading to
compensatory dopamine overactivity when off
D2-blocking medication, with resultant worsening of positive symptoms of psychosis.24

The co-occurring nature versus the consequential nature of gender dysphoria with psychotic
and/or mood disorders poses challenges in
proper diagnosis and appropriate treatment
choices. A review of the current literature
reports cases of both schizophrenia along with
gender dysphoria, as well as gender dysphoria
during mania, with up to 25% of patients living
with schizophrenia experiencing positive signs
of gender dysphoria throughout their lives.2,4
Distinguishing between both possibilities is
a diagnostic challenge, yet a fundamental
process affecting therapeutic decision-making. Before designating treatment options, a
thorough diagnostic evaluation should occur,
with the patient’s decision-making capacity
being well-established. Moreover, the unique
physical, mental, and social needs of this particular patient population must be taken into
consideration, especially to avoid any medical
barriers. Therefore, there is a considerable need
to expand the awareness and knowledge of and
experience with gender dysphoria patients, for
both general practitioners, as well as general
psychiatrists. Distinguishing between accurate
diagnoses of gender dysphoria is vital to ensure
that individuals receive proper care and management in each unique case, incorporating all
treatment leading up to and including gender
reassignment surgery. Thorough diagnostic
evaluations, physical exams, and the collection
of collateral information are all crucial factors
in diagnostic work-up and treatment planning. Additionally, as per WPATH, the patient’s
capacity to make decisions should be well-established before proceeding with all plans for
treatment.

Conclusion

This case demonstrated consistent female
identity with continuity across manic episodes,
from seeking laser body hair removal early on,

This case presentation depicts a clear pattern
of gender identity change from male to female coinciding solely with psychotic breaks
of schizoaffective disorder, bipolar type. The
authors postulate that gender dysphoria can
co-occur with other psychiatric disorders or as
a direct result of acute psychosis. It is important to note the distinction between “gender
dysphoria” and “transgender/gender non-binary identity”. As stated above, gender dysphoria
occurs when a discrepancy between one’s sex
assigned at birth and one’s gender identity
causes distress or impairment in function while
transgender/gender non-binary identity is an
umbrella term for people whose gender identity is different from the sex assigned to them
at birth. It is important to note that one can
occur without the other and not everyone with
gender dysphoria symptoms would benefit
from HRT, surgery, or other gender-affirming
interventions. On the other hand, many transgender individuals and gender non-binary individuals who do not meet the criteria for gender dysphoria may benefit considerably from
gender-affirming treatments. Additionally, the
authors consider that it would be noteworthy
to study gender variance during the various
stages of schizoaffective disorder to better
understand if gender dysphoria tends to occur
more during periods of psychotic episodes versus mood episodes.
The authors emphasize the critical importance
of distinguishing between the two presentations of gender dysphoria (co-occurring with
psychiatric disorders or as a direct result of
acute psychosis) to ensure an accurate diagnosis before proceeding with treatment for
gender concerns. A thorough diagnostic evalu-
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ation, physical examination, and the collection
of collateral information are all necessary steps
in the proper diagnosis and the allocation of
treatment planning. Additionally, the patient’s
capacity to make decisions should be well-established before proceeding with any plans for
treatment. Furthermore, emphasis should be
placed on the consideration of each case on an
individual basis with unique needs as the field
of medicine moves briskly towards recognizing
health equity at every level of medical attention.
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